JPH0656679A - クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物 - Google Patents
クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物Info
- Publication number
- JPH0656679A JPH0656679A JP2056596A JP5659690A JPH0656679A JP H0656679 A JPH0656679 A JP H0656679A JP 2056596 A JP2056596 A JP 2056596A JP 5659690 A JP5659690 A JP 5659690A JP H0656679 A JPH0656679 A JP H0656679A
- Authority
- JP
- Japan
- Prior art keywords
- cbm
- clostridium difficile
- blasts
- lactobacillus
- feces
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
ロストリジウム・ディフィシルの臨床分離株の性状は、
表4のとおりであった。」を追加。 (2)第13頁第5行「…表4に示す…」を、「…表5
に示す…」と訂正。 (3)第13頁第10行「…解消した。」の後に、「ク
ロストリジウム・ディフィシルの臨床分離株の性状は、
表6のとおりであった。」を追加。 (4)第15頁と第16頁の間に、別紙表4を挿入。 (5)第16頁第15行「表4」を、「表5」と訂正。 (6)第16頁と第17頁の間に、別紙表6を挿入。
Claims (1)
- 【請求項1】 酪酸菌の菌体または芽胞および糖類より
な るクロストリジウム・ディフィシル下痢症および 偽膜性大腸炎の予防ならびに治療用医薬組成物。
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2056596A JP2961182B2 (ja) | 1990-03-09 | 1990-03-09 | クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物 |
HU91705A HUT61478A (en) | 1990-03-09 | 1991-03-05 | Process for producing pharamceutical composition suitable for treating diarrhoae caused by clostridium difficile and by pseudomembranous colitis |
KR1019910003689A KR0145553B1 (ko) | 1990-03-09 | 1991-03-07 | 클로스트리듐 디피실레 하리증 및 위막성 대장염의 예방 및 치료용 의약조성물 |
EP91301955A EP0446069B1 (en) | 1990-03-09 | 1991-03-08 | Treatment of clostridium difficile diarrhoea and pseudomembranous colitis |
DE91301955T DE69100314T2 (de) | 1990-03-09 | 1991-03-08 | Behandlung von Clostridium difficile Diarrhöe und Pseudomembrankolitis. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2056596A JP2961182B2 (ja) | 1990-03-09 | 1990-03-09 | クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0656679A true JPH0656679A (ja) | 1994-03-01 |
JP2961182B2 JP2961182B2 (ja) | 1999-10-12 |
Family
ID=13031585
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2056596A Expired - Lifetime JP2961182B2 (ja) | 1990-03-09 | 1990-03-09 | クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0446069B1 (ja) |
JP (1) | JP2961182B2 (ja) |
KR (1) | KR0145553B1 (ja) |
DE (1) | DE69100314T2 (ja) |
HU (1) | HUT61478A (ja) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015537042A (ja) * | 2012-11-23 | 2015-12-24 | セレス セラピューティクス インコーポレイテッド | 相乗的細菌組成物並びにその生成及び使用の方法 |
JP2016509003A (ja) * | 2013-02-04 | 2016-03-24 | セレス セラピューティクス インコーポレイテッド | 組成物および方法 |
US9956282B2 (en) | 2013-12-16 | 2018-05-01 | Seres Therapeutics, Inc. | Bacterial compositions and methods of use thereof for treatment of immune system disorders |
US10076546B2 (en) | 2013-03-15 | 2018-09-18 | Seres Therapeutics, Inc. | Network-based microbial compositions and methods |
US10258655B2 (en) | 2013-11-25 | 2019-04-16 | Seres Therapeutics, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
US10864235B2 (en) | 2012-11-23 | 2020-12-15 | Seres Therapeutics, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
US10973861B2 (en) | 2013-02-04 | 2021-04-13 | Seres Therapeutics, Inc. | Compositions and methods |
US11701394B2 (en) | 2017-08-14 | 2023-07-18 | Seres Therapeutics, Inc. | Compositions and methods for treating cholestatic disease |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4572185B2 (ja) | 2006-08-28 | 2010-10-27 | ミヤリサン製薬株式会社 | 酪酸菌及び/又は乳酸菌を含有してなる消化管洗浄助剤 |
CA2811056A1 (en) * | 2010-09-10 | 2012-03-15 | Viropharma Incorporated | Environmental clostridial bacteriotherapy and related formulations and methods of manufacture and use |
BR112014021388A2 (pt) | 2012-02-29 | 2017-07-18 | Ethicon Endo Surgery Inc | composições de microbiota e métodos rela-cionados às mesmas |
GB2551642B (en) | 2014-10-31 | 2020-09-23 | Pendulum Therapeutics Inc | Methods and compositions relating to microbial treatment and diagnosis of disorders |
AU2018326705A1 (en) | 2017-08-30 | 2020-03-05 | Pendulum Therapeutics, Inc. | Methods and compositions for treatment of microbiome-associated disorders |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2678M (fr) * | 1962-07-11 | 1964-07-27 | Taisho Pharmaceutical Co Ltd | Application comme régulateur intestinal d'une préparation a base de clostridium butyricum en thérapeutique. |
GB1190386A (en) * | 1966-06-28 | 1970-05-06 | Green Cross Corp | Process for producing the Lactic Acid Bacteria Drugs |
-
1990
- 1990-03-09 JP JP2056596A patent/JP2961182B2/ja not_active Expired - Lifetime
-
1991
- 1991-03-05 HU HU91705A patent/HUT61478A/hu unknown
- 1991-03-07 KR KR1019910003689A patent/KR0145553B1/ko not_active IP Right Cessation
- 1991-03-08 EP EP91301955A patent/EP0446069B1/en not_active Expired - Lifetime
- 1991-03-08 DE DE91301955T patent/DE69100314T2/de not_active Expired - Lifetime
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2022028787A (ja) * | 2012-11-23 | 2022-02-16 | セレス セラピューティクス インコーポレイテッド | 相乗的細菌組成物並びにその生成及び使用の方法 |
US12083151B2 (en) | 2012-11-23 | 2024-09-10 | Seres Therapeutics, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
US11464812B2 (en) | 2012-11-23 | 2022-10-11 | Seres Therapeutics, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
US11458174B2 (en) | 2012-11-23 | 2022-10-04 | Seres Therapeutics, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
US11458173B2 (en) | 2012-11-23 | 2022-10-04 | Seres Therapeutics, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
US11389490B2 (en) | 2012-11-23 | 2022-07-19 | Seres Therapeutics, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
JP2015537042A (ja) * | 2012-11-23 | 2015-12-24 | セレス セラピューティクス インコーポレイテッド | 相乗的細菌組成物並びにその生成及び使用の方法 |
JP2019135240A (ja) * | 2012-11-23 | 2019-08-15 | セレス セラピューティクス インコーポレイテッド | 相乗的細菌組成物並びにその生成及び使用の方法 |
US10864235B2 (en) | 2012-11-23 | 2020-12-15 | Seres Therapeutics, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
JP2019116488A (ja) * | 2013-02-04 | 2019-07-18 | セレス セラピューティクス インコーポレイテッド | 組成物および方法 |
US10967011B2 (en) | 2013-02-04 | 2021-04-06 | Seres Therapeutics, Inc. | Compositions and methods |
US10973861B2 (en) | 2013-02-04 | 2021-04-13 | Seres Therapeutics, Inc. | Compositions and methods |
US11185562B2 (en) | 2013-02-04 | 2021-11-30 | Seres Therapeutics, Inc. | Compositions and methods for inhibition of pathogenic bacterial growth |
JP2016509003A (ja) * | 2013-02-04 | 2016-03-24 | セレス セラピューティクス インコーポレイテッド | 組成物および方法 |
US11730775B2 (en) | 2013-02-04 | 2023-08-22 | Seres Therapeutics, Inc. | Methods for treatment of Clostridium difficile infection or recurrence or symptoms thereof |
US10064901B2 (en) | 2013-02-04 | 2018-09-04 | Seres Therapeutics, Inc. | Compositions and methods |
US10076546B2 (en) | 2013-03-15 | 2018-09-18 | Seres Therapeutics, Inc. | Network-based microbial compositions and methods |
US11666612B2 (en) | 2013-03-15 | 2023-06-06 | Seres Therapeutics, Inc | Network-based microbial compositions and methods |
US10881696B2 (en) | 2013-03-15 | 2021-01-05 | Seres Therapeutics, Inc. | Network-based microbial compositions and methods |
US10258655B2 (en) | 2013-11-25 | 2019-04-16 | Seres Therapeutics, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
US11266699B2 (en) | 2013-11-25 | 2022-03-08 | Seres Therapeutics, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
US11918612B2 (en) | 2013-11-25 | 2024-03-05 | Seres Therapeutics, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
US9956282B2 (en) | 2013-12-16 | 2018-05-01 | Seres Therapeutics, Inc. | Bacterial compositions and methods of use thereof for treatment of immune system disorders |
US11701394B2 (en) | 2017-08-14 | 2023-07-18 | Seres Therapeutics, Inc. | Compositions and methods for treating cholestatic disease |
Also Published As
Publication number | Publication date |
---|---|
EP0446069A1 (en) | 1991-09-11 |
KR0145553B1 (ko) | 1998-08-17 |
DE69100314T2 (de) | 1993-12-16 |
HUT61478A (en) | 1993-01-28 |
KR910016338A (ko) | 1991-11-05 |
JP2961182B2 (ja) | 1999-10-12 |
DE69100314D1 (de) | 1993-10-07 |
EP0446069B1 (en) | 1993-09-01 |
HU910705D0 (en) | 1991-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0456418B1 (en) | Treatment of clostridium difficile diarrhoea and pseudomembranous colitis | |
US5266315A (en) | Composite for Clostridium difficile diarrhea and pseudomembranous colitis | |
JP5904688B2 (ja) | 共生乳酸産生細菌およびその使用 | |
Poth | Intestinal antisepsis in surgery | |
AU662601B2 (en) | Probiotic for control of salmonella | |
US5733579A (en) | Oral rehydration solution containing indigestible oligosaccharides | |
JPH0656679A (ja) | クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物 | |
Wiegersma et al. | Effect of twelve antimicrobial drugs on the colonization resistance of the digestive tract of mice and on endogenous potentially pathogenic bacteria | |
JPH0443079B2 (ja) | ||
US20090263416A1 (en) | Reduction of antibiotic resistance in bacteria | |
US5658887A (en) | Pharmaceutical formulations comprising a clavulanic acid salt and erithromycin derivatite | |
EP0820292B1 (en) | Inhibition of c. difficile infections by indigestible oligosaccharides | |
CN111821322A (zh) | 一种可替代抗生素的禽用微生态口服制剂及其应用 | |
CN117511773B (zh) | 一株粪肠球菌、复合菌剂及其应用 | |
US5688777A (en) | Inhibition of C. difficile infections by indigestible oligosaccharides | |
Ruijs et al. | The effect of norfloxacin and of rosoxacin on the colonization resistance of the digestive tract in mice | |
CN101890020A (zh) | 一种头孢匹林钠和克拉维酸钾的组合物及其配比 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070806 Year of fee payment: 8 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080806 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080806 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090806 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100806 Year of fee payment: 11 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100806 Year of fee payment: 11 |